JOTA Publication: The STF and Pharmaceutical Assistance in SUS: A Bitter Medicine?
October 14, 2024 The RB Advogados team analyzed the recent STF decision […]
October 14, 2024
The RB Advogados team analyzed the recent STF decision regarding the judicial provision of non-standardized medications in SUS, which sets stricter criteria, such as the analysis by Conitec and scientific proof of the medication’s effectiveness. The measure aims to align the Judiciary with Executive policies but restricts access to innovative treatments, especially due to cost issues. The decision seeks a more effective management of public resources, although it has faced criticism regarding the limitation on access to high-cost medications.
Read the full publication: https://www.jota.info/artigos/o-stf-e-a-assistencia-farmaceutica-no-sus-um-remedio-amargo
